Yahoo
HKSE - Delayed Quote HKD

Beijing Biostar Pharmaceuticals Co., Ltd. (2563.HK)

3.700 +0.300 (+8.82%)
As of 10:40:07 AM GMT+8. Market Open.
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
55,212.939
33,364.260
71,865.552
66,635
32,820
Cost of Revenue
4,122.579
2,606.963
9,745.140
19,810
8,940
Gross Profit
51,090.359
30,757.297
62,120.412
46,825
23,880
Operating Expense
126,350.330
147,327.396
204,946.838
264,804
224,018
Operating Income
-75,259.971
-116,570.099
-142,826.427
-217,979
-200,138
Net Non Operating Interest Income Expense
15,381.113
16,007.235
15,512.815
13,081
3,270
Pretax Income
-103,988.479
-131,435.109
-143,776.518
-189,644
-160,511
Tax Provision
0
--
0
0
0
Net Income Common Stockholders
-103,988.479
-131,435.109
-143,776.518
-189,644
-160,511
Diluted NI Available to Com Stockholders
-103,988.479
-131,435.109
-143,776.518
-189,644
-160,511
Basic EPS
-0.28
0.53
--
-0.52
-0.44
Diluted EPS
-0.28
0.53
--
-0.52
-0.44
Basic Average Shares
365,097.524
364,588
352,478
364,588
364,588
Diluted Average Shares
365,097.524
364,588
352,478
364,588
364,588
Total Operating Income as Reported
-105,277.561
-134,347.145
-143,569.892
-189,587
-160,440
Rent Expense Supplemental
--
--
5
--
--
Total Expenses
130,472.910
149,934.360
214,691.978
284,614
232,958
Net Income from Continuing & Discontinued Operation
-103,988.479
-131,435.109
-143,776.518
-189,644
-160,511
Normalized Income
-83,801.125
-110,741.309
-122,119.045
-200,025
-170,148
Interest Income
15,477.956
16,102.043
15,622.800
13,138
3,341
Interest Expense
50.890
46.310
55.606
57
71
Net Interest Income
15,381.113
16,007.235
15,512.815
13,081
3,270
EBIT
-103,937.589
-131,388.799
-143,720.913
-189,587
-160,440
EBITDA
-101,807.440
-120,770.929
-133,915.376
-178,965
-149,938
Reconciled Cost of Revenue
4,122.579
2,606.963
9,745.140
19,810
8,940
Reconciled Depreciation
2,130.148
10,617.870
9,805.536
10,622
10,502
Net Income from Continuing Operation Net Minority Interest
-103,988.479
-131,435.109
-143,776.518
-189,644
-160,511
Total Unusual Items Excluding Goodwill
-20,187.354
-20,693.799
-21,657.473
10,381
9,637
Total Unusual Items
-20,187.354
-20,693.799
-21,657.473
10,381
9,637
Normalized EBITDA
-81,620.086
-100,077.130
-112,257.903
-189,346
-159,575
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 10/31/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: